Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Y-mAbs Therapeutics | YMAB | Apr 30, 2024 | 15.21 | -1.87 |
Yalla ADR | YALA | Apr 30, 2024 | 4.70 | -1.05 |
Yatra Online | YTRA | Apr 30, 2024 | 1.46 | +2.82 |
Yatsen ADR | YSG | Apr 30, 2024 | 4.37 | -2.67 |
Yelp | YELP | Apr 30, 2024 | 40.24 | -1.66 |
YETI | YETI | Apr 30, 2024 | 35.72 | -3.46 |
Yext | YEXT | Apr 30, 2024 | 5.49 | -1.79 |
Yield10 Bioscience | YTEN | Apr 30, 2024 | 0.24 | +4.75 |
Yieldshares High Income ETF | YYY | Apr 30, 2024 | 11.61 | -0.60 |
Yiren Digital ADR | YRD | Apr 30, 2024 | 5.04 | +0.40 |
York Water | YORW | Apr 30, 2024 | 35.51 | -0.03 |
Yoshiharu Global A | YOSH | Apr 30, 2024 | 3.75 | +0.54 |
Yoshitsu ADR | TKLF | Apr 30, 2024 | 0.22 | -2.10 |
Yotta Acquisition | YOTA | Apr 30, 2024 | 10.67 | 0.00 |
Yotta Acquisition Unit | YOTAU | Apr 30, 2024 | 11.74 | 0.00 |
Youdao A ADR | DAO | Apr 30, 2024 | 3.50 | -1.96 |
YPF Sociedad Anonima ADR | YPF | Apr 30, 2024 | 21.96 | +2.23 |
YS Biopharma | YS | Apr 30, 2024 | 0.70 | -8.57 |
Yum China | YUMC | Apr 30, 2024 | 36.51 | -8.82 |
Yum! Brands | YUM | Apr 30, 2024 | 141.25 | -1.35 |
Yunhong Green CTI | YHGJ | Apr 30, 2024 | 1.35 | -2.88 |
Yunji ADR | YJ | Apr 30, 2024 | 0.82 | +6.61 |
YY Group Holding | YYGH | Apr 30, 2024 | 2.36 | 0.00 |
Zai Lab ADR | ZLAB | Apr 30, 2024 | 15.80 | -1.99 |
Zalatoris II Acquisition | ZLS | Apr 30, 2024 | 10.88 | 0.00 |
Zapata Computing | ZPTA | Apr 30, 2024 | 1.35 | 0.00 |
Zapp Electric Vehicles Group | ZAPP | Apr 30, 2024 | 2.55 | -7.94 |
ZC SP ETN REDEEM 19/07/2050 USD 25 - Ser B | AMND | Apr 30, 2024 | 42.85 | -1.71 |
ZC SP ETN REDEEM 20/10/2050 USD 25 - Series B | AMTR | Apr 30, 2024 | 57.29 | -2.00 |
Zebra Technologies A | ZBRA | Apr 30, 2024 | 314.56 | +4.85 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.